You are here

  • Home
  • Archive
  • Volume 16, Issue 5
  • Oral rivaroxaban for acute DVT, or long term for VTE, is as effective as enoxaparin followed by a vitamin K antagonist for preventing recurrence, with no increase in bleeding complications

Article info

Article menu
Download PDFPDF
Therapeutics
Randomised controlled trial
Oral rivaroxaban for acute DVT, or long term for VTE, is as effective as enoxaparin followed by a vitamin K antagonist for preventing recurrence, with no increase in bleeding complications

Authors

  1. Correspondence to David J Rosenberg
    North Shore University Hospital, 300 Community Drive, Manhasset, NY 11030, USA; drosenbe{at}nshs.edu
View Full Text

Citation

Rosenberg DJ, Ansell J
Oral rivaroxaban for acute DVT, or long term for VTE, is as effective as enoxaparin followed by a vitamin K antagonist for preventing recurrence, with no increase in bleeding complications
BMJ Evidence-Based Medicine 2011;16:139-140.

Publication history

  • First published April 3, 2011.
Online issue publication 
October 25, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions